Pharmaceutical companies are using legal settlements with generic drug makers to delay the introduction of cheaper medicines, a government agency said Wednesday. In a 12-month period that ended last Sept. 30, 14 of 33 agreements to settle patent litigation between brand-name drug companies and...
[read full story]